Multiplex blood-test and Magnetic Resonance Imaging (MRI) for prostate cancer screening: Results from the 2nd screening round in the STHLM3-MRI trial

被引：0

作者：

Discacciati, A. ^{[1
]}

Abbadi, A. ^{[1
]}

Chandra, J. ^{[2
]}

Annerstedt, M. ^{[3
]}

Glaessgen, A. ^{[4
]}

Carlsson, S. ^{[5
]}

Jaderling, F. ^{[5
]}

Gronberg, H. ^{[1
]}

Eklund, M. ^{[1
]}

Nordstrom, T. ^{[1
]}

机构：

[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden

[2] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden

[3] Dept Urol, C Med, Stockholm, Sweden

[4] Unilabs, Dept Pathol, Stockholm, Sweden

[5] Karolinska Inst, Dept Mol Med, Stockholm, Sweden

来源：

EUROPEAN UROLOGY | 2024年 / 85卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A0664

引用

页码：S1611 / S1611

页数：1

共 37 条

[21] Magnetic resonance imaging in oesophageal (oes) cancer: Results from the STO3 MRI substudy
Davidson, M.
Nankivell, M.
Cunningham, D.
Starling, N.
Koh, D-M.
Brown, G.
Allum, W.
Wotherspoon, A.
Smyth, E.
Ly, L.
Kleovoulou, N.
Langley, R.
Riddell, A.
ANNALS OF ONCOLOGY, 2018, 29
[22] Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial-Prostate Cancer Secondary Screening in Sapienza (PROSA)
Messina, Emanuele
La Torre, Giuseppe
Pecoraro, Martina
Pisciotti, Martina Lucia
Sciarra, Alessandro
Poscia, Roberto
Catalano, Carlo
Panebianco, Valeria
EUROPEAN RADIOLOGY, 2024, 34 (01) : 204 - 213
[23] Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) Trial
Lehman, CD
Blume, JD
Thickman, D
Bluemke, DA
Pisano, E
Kuhl, C
Julian, TB
Hylton, N
Weatherall, P
O'Loughlin, M
Schnitt, SJ
Gatsonis, C
Schnall, MD
JOURNAL OF SURGICAL ONCOLOGY, 2005, 92 (01) : 9 - 15
[24] Re: Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial
Ortegon, Jose D. Cardona
Perilla, Laura A. Campana
Bermudez, Laura M. Olarte
EUROPEAN UROLOGY, 2024, 86 (01)
[25] MAGNETIC RESONANCE IMAGING-BASED PROSTATE CANCER SCREENING: DIFFERENCES IN THE COSTEFFECTIVENESS USING EVIDENCE FROM DIAGNOSTIC COHORTS VERSUS SCREENING-BY-INVITATION TRIAL
Hao, S.
Clements, M. S.
VALUE IN HEALTH, 2022, 25 (12) : S67 - S67
[26] Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) Trial - Commentary
Bland, KI
JOURNAL OF SURGICAL ONCOLOGY, 2005, 92 (01) : 15 - 16
[27] Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
Nordstrom, Tobias
Jaderling, Fredrik
Carlsson, Stefan
Aly, Markus
Gronberg, Henrik
Eklund, Martin
BMJ OPEN, 2019, 9 (06):
[28] Screening in women at genetic risk of breast cancer: Results of the UK multicentre study of magnetic resonance imaging (MRI) and X-ray mammography (XRM).
Leach, MO
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 9S - 9S
[29] Magnetic resonance imaging detects significant prostate cancer and could be used to reduce unnecessary biopsies: initial results from a prospective trial of MRI in men planned for diagnostic biopsy
Thompson, J.
Stricker, P.
Brenner, P.
Shnier, R.
Moses, D.
Delprado, W.
Hayen, A.
Haynes, A-M.
Matthews, J.
BJU INTERNATIONAL, 2013, 111 : 97 - 97
[30] Prostate cancers detected in the PSA interval 1.8-3 ng/mL - results from the Goteborg 2 prostate cancer screening trial
Billig, Moller F.
Mansson, M.
Wallstrom, J.
Hellstrom, M.
Hugusson, J.
Godtman, Arnsrud R.
EUROPEAN UROLOGY, 2023, 83

← 1 2 3 4 →